TrianglePUBLICATIONS · 18202422
Randomized, phase III study of weekly paclitaxel in combination with carboplatin versus standard every-3-weeks administration of carboplatin and paclitaxel for patients with previously untreated advanced non-small-cell lung cancer.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 2008 Jan 20
- First author
- Belani CP
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Belani CP
- type
- Author
- name
- Ramalingam S
- type
- Author
- name
- Perry MC
- type
- Author
- name
- LaRocca RV
- type
- Author
- name
- Rinaldi D
- type
- Author
- name
- Gable PS
- type
- Author
- name
- Tester WJ
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Belani CP
- type
- Author
- name
- Ramalingam S
- type
- Author
- name
- Perry MC
- type
- Author
- name
- LaRocca RV
- type
- Author
- name
- Rinaldi D
- type
- Author
- name
- Gable PS
- type
- Author
- name
- Tester WJ
- type
- Author
- bibliography ids
- nci-bib-3f466e4be9eac5ec47600e28
- book metadata
- content sha256
- ad99a909ee753a8246f89128f71e1531d2e46ee3a526cf56668de3f146c075bb
- document type
- citation
- dois
- 10.1200/JCO.2007.13.1912
- electronic publication date
- display
- Source null
- precision
- missing
- year
- Source null
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:18202422
- immutable id
- pubmed:18202422@ad99a909ee753a8246f89128f71e1531d2e46ee3a526cf56668de3f146c075bb
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- 1527-7755
- issn print
- 0732-183X
- issue
- 3
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 468-73
- volume
- 26
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 18202422
- provenance
- batch id
- 89a0f2206e11ca092d02
- provider
- NCBI PubMed ESummary
- record sha256
- 972378d9128e83969d657aeb62cfeb7a3383536bb3094315fefd53b5a99d45ff
- response sha256
- 7b1c355120884a7a596bcf7b4a243dc12308b7f7f0914c3fc71b0c8e8d79c708
- retrieved at
- 2026-09-09T23:46:16.784581+00:00
- publication date
- display
- 2008 Jan 20
- precision
- day
- year
- 2008
- publication types
- Clinical Trial, Phase III
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Randomized, phase III study of weekly paclitaxel in combination with carboplatin versus standard every-3-weeks administration of carboplatin and paclitaxel for patients with previously untreated advanced non-small-cell lung cancer.
Preserved source evidence · Not medical advice